Review undertaken in November 2006 making reference to the role of recruitment ... application process just about right; could though be bordering on too much ...
Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, UK ... Methotrexate 30 mg/m2. Vinblastine 3 mg/m2. Adriamycin 30 mg /m2. Cisplatin 70 mg /m2 ...
Promoting efficient and effective data collection throughout ... Urology. tbc. SWPHO/CIS. Julia Verne. Robert Huddart. John Kelly. Noel Clarke. Barry Hancock ...
A few tips. Develop your own and systematic view of the world. Write down your ideas ... Simplicity is beauty. Logical arguments. Satisfy reviewers' concerns ...
Why do we follow-up patients who have had germ cell tumors? ... Oldenburg, Martin & Fossa J Clin Oncol 24: 5503-11, 2006. Localization of late relapses ...
Growth in institutional equity investment in the United States ... Klemkosky (1977), Kraus and Stoll (1972), Lakonishok, Shleifer and Vishny (1992) ...
Facts and Figures. Harvard Report 2006 Why do we lose customers? ... And You Thought Strawberries Were For Eating! Style of Feedback. Overnight stay ...
Hall and Murphy (2003) the average outstanding amount of ESOs for an average S&P ... Murphy (2003): over the 1990s, the stock option component of CEO pay for the S&P ...
Assess contributions made by philanthropic and community employment organizations ... African American Worker's Union 1980s, more equitable uplift of blacks both ...
Classification of Prognostic factors. Prognostic Models in Testis ... Jeremy Sturgeon. Malcolm Moore. Pathology. Diponkar Banarjee. Joan Sweet. Andrew Evans ...
Can more data hurt? Count on auditors. Modifications to option pricing models? ... Carpenter, Jennifer, ' The exercise and valuation of executive stock options, ...
To compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in patients with asymptomatic or mildly symptomatic patients ...